| ALT | Alternative lengthening of telomere |
| ChIP-on-Chip | Immunoprecipitation on chip |
| DDR | DNA damage response |
| DN | Dominant negative |
| ER | Endoplasmic reticulum |
| ES cells | Early-stage p53S/++Ras cells, senescent cells |
| GOF | Gain of function |
| IF | Immunofluorescence staining |
| LFL | Li–Fraumeni like |
| LFS | Li–Fraumeni syndrome |
| LOF | Loss of function |
| LOH | Loss of heterozygosity |
| LS cells | Late-stage p53S/++Ras cells, which bypassed the OIS |
| MEFs | Mouse embryonic fibroblasts |
| OIS | Oncogene-induced senescence |
| p53S | p53N236S |
| PDAC | Pancreatic ductal adenocarcinoma |
| PDH | Pyruvate dehydrogenase |
| PGC–1α | PPARγ coactivator |
| PPARγ | Peroxisome proliferator-activated receptor γ |
| ROS | Reactive oxygen species |
| SCID | Severe combined immune deficiency |
| WT | Wild type |